Details
Stereochemistry | ACHIRAL |
Molecular Formula | C28H38N2O6 |
Molecular Weight | 498.6111 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC1=CC(OC)=C(OCC(=O)N2CCN(CC2)C(=O)COC3=CC=C(CCC)C=C3OC)C=C1
InChI
InChIKey=IMOLVSPMDGCLMB-UHFFFAOYSA-N
InChI=1S/C28H38N2O6/c1-5-7-21-9-11-23(25(17-21)33-3)35-19-27(31)29-13-15-30(16-14-29)28(32)20-36-24-12-10-22(8-6-2)18-26(24)34-4/h9-12,17-18H,5-8,13-16,19-20H2,1-4H3
DescriptionCurator's Comment: Description was created based on several sources, including http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=1609
Curator's Comment: Description was created based on several sources, including http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=1609
Simetride is a non-narcotic analgesic, it is an ingredient of Kyorin AP2 (a combination of Simetride and Anhydrous Caffeine (40:1)) in Japan. Kyorin AP2 is used to treat low back pain, symptomatic neuralgia, headache, menstrual pain, pharyngalgia/earache due to inflammation, toothache, postoperative pain.
CNS Activity
Approval Year
Sample Use Guides
The usual adult dosage for oral use is 0.5 g of Simetride three or four times daily
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3349478
Simetride (3ug/ml) exhibited a significant VCR uptake-enhancing effect by leukemia P388/VCR cells.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Fri Dec 15 16:11:06 GMT 2023 , Edited by admin on Fri Dec 15 16:11:06 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2104924
Created by
admin on Fri Dec 15 16:11:06 GMT 2023 , Edited by admin on Fri Dec 15 16:11:06 GMT 2023
|
PRIMARY | |||
|
4883
Created by
admin on Fri Dec 15 16:11:06 GMT 2023 , Edited by admin on Fri Dec 15 16:11:06 GMT 2023
|
PRIMARY | |||
|
C72129
Created by
admin on Fri Dec 15 16:11:06 GMT 2023 , Edited by admin on Fri Dec 15 16:11:06 GMT 2023
|
PRIMARY | |||
|
SUB10526MIG
Created by
admin on Fri Dec 15 16:11:06 GMT 2023 , Edited by admin on Fri Dec 15 16:11:06 GMT 2023
|
PRIMARY | |||
|
m1249
Created by
admin on Fri Dec 15 16:11:06 GMT 2023 , Edited by admin on Fri Dec 15 16:11:06 GMT 2023
|
PRIMARY | Merck Index | ||
|
2282
Created by
admin on Fri Dec 15 16:11:06 GMT 2023 , Edited by admin on Fri Dec 15 16:11:06 GMT 2023
|
PRIMARY | |||
|
DTXSID2057651
Created by
admin on Fri Dec 15 16:11:06 GMT 2023 , Edited by admin on Fri Dec 15 16:11:06 GMT 2023
|
PRIMARY | |||
|
71622
Created by
admin on Fri Dec 15 16:11:06 GMT 2023 , Edited by admin on Fri Dec 15 16:11:06 GMT 2023
|
PRIMARY | |||
|
QU6P2P8XLW
Created by
admin on Fri Dec 15 16:11:06 GMT 2023 , Edited by admin on Fri Dec 15 16:11:06 GMT 2023
|
PRIMARY | |||
|
154-82-5
Created by
admin on Fri Dec 15 16:11:06 GMT 2023 , Edited by admin on Fri Dec 15 16:11:06 GMT 2023
|
PRIMARY | |||
|
100000083515
Created by
admin on Fri Dec 15 16:11:06 GMT 2023 , Edited by admin on Fri Dec 15 16:11:06 GMT 2023
|
PRIMARY |
ACTIVE MOIETY